Main Menu

Cannabidiol significantly reduces seizures in patients with severe form of epilepsy

Cannabidiol significantly reduces seizures in patients with severe form of epilepsy

|

Cannabidiol (CBD), a compound derived from the cannabis plant that does not produce a “high” and has been an increasing focus of medical research, was shown in a new large-scale, randomized, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox-Gastaut syndrome.

In the new study comparing two doses of CBD to a placebo, the researchers reported a 41.9 percent reduction in “drop seizures” – a type of seizure that results in severe loss of muscle control and balance – in patients taking a 20 mg/kg/d CBD regimen, a 37.2 percent reduction in those on a 10 mg/kg/d CBD regimen, and a 17.2 percent reduction in a group given a placebo.

Cannabidiol significantly reduces seizures in patients with severe form of epilepsy






Comments are Closed